Piramal: White Papers

The challenge of catering to the prolific sterile injectables market
Tuesday, September 27, 2016 Head of strategy for international business Sameer Kolhe and strategic marketing manager Shveta Kulkarni explain how Piramal Pharma Solutions’ new US manufacturing facility will help...

Designer quality
Thursday, November 05, 2015 Quality by design (QbD) is a systematic, scientific, quantitative and enhanced approach to process development that ensures quality is not just tested in the final drug substance but...

Piramal Healthcare invests $2.5 million to further expand commercial ADC capacity
Tuesday, February 11, 2014 Piramal’s healthcare vertical has announced that it is to invest $2.5 million at its FDA-approved site in Grangemouth, UK, to upgrade one of its antibody drug conjugate...

Primal Healthcare to invest $11 million in hormonal healthcare production at its Morpeth, UK, facility
Tuesday, February 11, 2014 Piramal Healthcare has announced that it is to invest $11 million at its Morpeth, UK, facility to triple the production capacity for hormonal products including contraceptive pills...


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.